The effect of medicinal plants on proliferation of human SW620 colorectal cancer cells by Zhumabekova, M. et al.
T H E E F F E C T OF MEDICINAL PLANTS ON P R O L I F E R A T I O N OF HUMAN SW620 
C O L O R E C T A L CANCER C E L L S 
M. Zhumabekova* , M. Zhunusova , A. Issabekova , V. Ogay 
Laboratory of Stem Cells, National Center for Biotechnology (Astana, Kazakhstan) 
L.N. Gumilyov Eurasian National University (Astana, Kazakhstan) 
marzhan.zhumabekova@nu.edu.kz 
Keywords: Colorectal cancer, medicinal plants, SW620 
Introduction: Colorectal cancer is currently one of the most common malignancies and the third 
leading cause of cancer-related deaths worldwide. Mortality is attributed to invasion and metastasis, 
with only 12.5% five-year survival rate for patients with distant metastasis. Chemotherapy is routinely 
used for cancer treatment. However, it is accompanied by a number of undesired side effects that can 
put the patients under further strain. Therefore, research interest is drawing its attention towards 
alternative treatments with less toxic side effects. Medicinal plants have a wide spectrum of 
pharmacological properties such as anti-carcinogenic, anti-inflammatory, anti-oxidative, anti-bacterial, 
etc. Medicinal plants as natural reservoirs of various secondary metabolites possess chemoprotective 
potential in anticancer therapies. In this study, we investigated the effect of five medicinal plant 
(Celandine (Chelidonium majus), Fenugreek (Trigonellafoenum-graecum), Sanguisorba officinalis, 
Chaga mushroom (Inonotus obliquus), Carumcarvi) extracts on viability of human metastatic colon 
cancer cells in comparison with two common chemotherapy drugs, 5-fluorouracil and oxaliplatin. 
Methods: Human colon cancer cells from lymph node metastasis (SW620) were cultured in both 
high-glucose and low-glucose DMEM supplemented with 10% FBS for glucose starvation prior to 
administration of inhibiting agents, and grown at 37°C under 5% CO2. The cytotoxicity of 0.5% and 1% 
aqueous plant extracts, 5-fluorouracil (250Lig/ml), and oxaliplatin (250LLM) was determined by Alamar 
Blue® cell viability assay. 
Results: Among all plant extracts and chemotherapy drugs, SW620 cells were more sensitive to 
fenugreek seeds at 1% concentration, as demonstrated by 1.3 and 1.2-fold reduction in cell viability 
compared to the effect of oxaliplatin and 5-fluorouracil, respectively. Fenugreek inhibited cell growth in 
a dose-dependent manner, with less profound difference in anti-cancer activity at a concentration of 
0.5%. The response of cancer cells to Carumcarvi and to Chelidonium majus was similar to the 
response to conventional chemotherapeutic drugs. Water extracts of Sanguisorba officinalis and 
Inonotus obliquus did not have significant effect on proliferation of cancer cells. Glucose starvation 
before the experiment revealed increased resistance of SW620 cells to an inhibiting agent. 
Conclusion: Our results prove the prospects of using medicinal plants as an alternative to or in 
combination with chemotherapy, especially in multidrug-resistant cancer types. 
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